Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Investigating the immune system

07.01.2013
Immune cells undergo complex processes during their development. If errors occur, the consequences for those who are affected can be fatal. Scientists from the University of Würzburg have now uncovered new details of what happens. These could be a target for new therapies.
As recently as a few decades ago, the following response was feared: following an organ transplant, the patient’s immune system recognizes the transplanted organ as “foreign” and therefore attacks and rejects it. It was not until the discovery, nearly 30 years ago, that the mycotoxin cyclosporin A can prevent the rejection of a transplanted organ that this response lost its capacity to terrify.

“In T cells, which are important cells in the immune system, cyclosporin A inhibits the activation of a group of transcription factors called NFAT factors,” explains Professor Edgar Serfling, a researcher at the University of Würzburg’s Institute of Pathology. At the time, this finding was tantamount to a “revolution in transplantation medicine”. “Thousands of patients owe their lives to cyclosporin A and the inhibition of NFAT factors,” says Serfling.

Now Serfling, his Research Associate Amiya K. Patra, and other scientists at the University of Würzburg have uncovered new details of the interaction between transcription factors and immune cells. Their work has just been published online in the journal Nature Immunology.

The development of T cells

To enable T cells to recognize transplanted organs or pathogenic viruses and bacteria as foreign material, they first have to be “educated”. This education takes place in the thymus – hence the name T cells. There, the immigrant progenitor cells of the cells later known as thymocytes are subjected to various selection processes in which NFAT factors also play an important role. “If errors occur in these processes, this often leads to autoimmune diseases, such as multiple sclerosis, psoriasis, and rheumatism,” explains Serfling. In multiple sclerosis, for example, autoreactive T cells in the brain attack the myelin sheaths of nerve cells, causing the fatal symptoms of this disease.

In the thymus, thymocyte progenitors develop special receptors on their surface where the body’s own transmitter interleukin 7 (IL-7) can dock. After it has docked, IL-7 transmits signals that activate or deactivate numerous genes in the cells. The progenitor cells subsequently divide and evolve into mature thymocytes.
New insights into the development process

As Amiya Patra has now revealed, NFAT factors also play a significant part in these processes: “If a specific NFAT factor is deactivated in mice, the thymocytes remain in their earliest stage of development and no thymus is created,” explains Serfling. However, if the early steps of thymocyte development that are controlled by IL-7 proceed without disruption, the cell soon forms other receptors that are important to its development and the IL-7 receptor disappears.

Though it is not just the absence of the NFAT factor that disrupts cell development; an excess also messes up the process: the development of thymocytes stops, but at a later stage in this case, and again with fatal consequences: “Specific progenitor receptors are created in an uncontrolled manner, with the result that the person affected develops leukemia, and NFAT factors play a critical role in this too,” explains Serfling.

Approach for new therapies

Through their work the Würzburg team has demonstrated that NFAT factors are critically involved not only in the recognition of the body’s own tissue and in immune responses, but also in the “education” of T cells in the thymus. They therefore represent a target structure that will play a key role in therapies for autoimmune diseases and leukemia in the future.

“An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development”. Amiya K Patra, Andris Avots, René P Zahedi, Thomas Schüler, Albert Sickmann, Ursula Bommhardt & Edgar Serfling; Nature Immunology, doi:10.1038/ni.2507

Contact

Prof. Dr. Edgar Serfling, T: +49 (0)931 31-81207,
e-mail: serfling.e@mail.uni-wuerzburg.de

Robert Emmerich | idw
Further information:
http://www.uni-wuerzburg.de

More articles from Life Sciences:

nachricht Show me your leaves - Health check for urban trees
12.12.2017 | Gesellschaft für Ökologie e.V.

nachricht Liver Cancer: Lipid Synthesis Promotes Tumor Formation
12.12.2017 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Long-lived storage of a photonic qubit for worldwide teleportation

12.12.2017 | Physics and Astronomy

Multi-year submarine-canyon study challenges textbook theories about turbidity currents

12.12.2017 | Earth Sciences

Electromagnetic water cloak eliminates drag and wake

12.12.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>